|
1
|
Ehara S, Ueda M, Naruko T, Haze K, Itoh A,
Otsuka M, Komatsu R, Matsuo T, Itabe H and Takano T: Elevated
levels of oxidized low density lipoprotein show a positive
relationship with the severity of acute coronary syndromes.
Circulation. 103:1955–1960. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Verhoye E and Langlois: Asklepios
Investigators: Circulating oxidized low-density lipoprotein: A
biomarker of atherosclerosis and cardiovascular risk? Clin Chem Lab
Med. 47:128–137. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Itabe H: Oxidized low-density lipoprotein
as a biomarker of in vivo oxidative stress: From atherosclerosis to
periodontitis. J Clin Biochem Nutr. 51:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Imanishi T, Hano T, Sawamura T, Takarada S
and Nishio I: Oxidized low density lipoprotein potentiation of
Fas-induced apoptosis through lectin-like oxidized-low density
lipoprotein receptor-1 in human umbilical vascular endothelial
cells. Circ J. 66:1060–1064. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bekkering S, Quintin J, Joosten LA, van
der Meer JW, Netea MG and Riksen NP: Oxidized low-density
lipoprotein induces long-term proinflammatory cytokine production
and foam cell formation via epigenetic reprogramming of monocytes.
Arterioscler Thromb Vasc Biol. 34:1731–1738. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen J, Mehta JL, Haider N, Zhang X,
Narula J and Li D: Role of caspases in Ox-LDL-induced apoptotic
cascade in human coronary artery endothelial cells. Circ Res.
94:370–376. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Galis ZS, Sukhova GK, Lark MW and Libby P:
Increased expression of matrix metalloproteinases and matrix
degrading activity in vulnerable regions of human atherosclerotic
plaques. J Clin Invest. 94:2493–2503. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Falk E, Shah PK and Fuster V: Coronary
plaque disruption. Circulation. 92:657–671. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Galis ZS and Khatri JJ: Matrix
metalloproteinases in vascular remodeling and atherogenesis: The
good, the bad and the ugly. Circ Res. 90:251–262. 2002.PubMed/NCBI
|
|
10
|
Visse R and Nagase H: Matrix
metalloproteinases and tissue inhibitors of metalloproteinases:
Structure, function and biochemistry. Circ Res. 92:827–839. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kuzuya M and Iguchi A: Role of matrix
metalloproteinases in vascular remodeling. J Atheroscler Thromb.
10:275–282. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Flamant M, Placier S, Dubroca C, Esposito
B, Lopes I, Chatziantoniou C, Tedgui A, Dussaule JC and Lehoux S:
Role of matrix metalloproteinases in early hypertensive vascular
remodeling. Hypertension. 50:212–218. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sukhova GK, Schonbeck U, Rabkin E, Schoen
FJ, Poole AR, Billinghurst RC and Libby P: Evidence for increased
collagenolysis by interstitial collagenases-1 and −3 in vulnerable
human atheromatous plaques. Circulation. 99:2503–2509. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Herman MP, Sukhova GK, Libby P, Gerdes N,
Tang N, Horton DB, Kilbride M, Breitbart RE, Chun M and Schönbeck
U: Expression of neutrophil collagenase (matrix
metalloproteinase-8) in human atheroma: A novel collagenolytic
pathway suggested by transcriptional profiling. Circulation.
104:1899–1904. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nikkari ST, O'Brien KD, Ferguson M,
Hatsukami T, Welgus HG, Alpers CE and Clowes AW: Interstitial
collagenase (MMP-1) expression in human carotid atherosclerosis.
Circulation. 92:1393–1398. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rajavashisth TB, Xu XP, Jovinge S, Meisel
S, Xu XO, Chai NN, Fishbein MC, Kaul S, Cercek B, Sharifi B and
Shah PK: Membrane type 1 matrix metalloproteinase expression in
human atherosclerotic plaques: Evidence for activation by
proinflammatory mediators. Circulation. 99:3103–3109. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu XP, Meisel SR, Ong JM, Kaul S, Cercek
B, Rajavashisth TB, Sharifi B and Shah PK: Oxidized low-density
lipoprotein regulates matrix metalloproteinase-9 and its tissue
inhibitor in human monocyte-derived macrophages. Circulation.
99:993–998. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Roivainen M, Viik-Kajander M, Palosuo T,
Toivanen P, Leinonen M, Saikku P, Tenkanen L, Manninen V, Hovi T
and Mänttäri M: Infections, inflammation and the risk of coronary
heart disease. Circulation. 101:252–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ravnskov U and McCully KS: Infections may
be causal in the pathogenesis of atherosclerosis. Am J Med Sci.
344:391–394. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hechter RC, Budoff M, Hodis HN, Rinaldo
CR, Jenkins FJ, Jacobson LP, Kingsley LA, Taiwo B, Post WS,
Margolick JB and Detels R: Herpes simplex virus type 2 (HSV-2) as a
coronary atherosclerosis risk factor in HIV-infected men:
Multicenter AIDS cohort study. Atherosclerosis. 223:433–436. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gurevich VS, Pleskov VM, Levaia MV,
Bannikov AI, Mitrofanova LB and Urazgil'Deeva SA: Influenza virus
infection in progressing atherosclerosis. Kardiologiia. 42:21–24.
2002.PubMed/NCBI
|
|
22
|
Auer J, Berent R, Weber T and Eber B:
Influenza virus infection, infectious burden and atherosclerosis.
Stroke. 33:1454–1455. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Streblow DN, Orloff SL and Nelson JA: Do
pathogens accelerate atherosclerosis? J Nutr. 131:2798S–2804S.
2001.PubMed/NCBI
|
|
24
|
Söderberg-Nauclér C: Does cytomegalovirus
play a causative role in the development of various inflammatory
diseases and cancer? J Intern Med. 259:219–246. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Epstein SE, Zhou YF and Zhu J: Infection
and atherosclerosis: Emerging mechanistic paradigms. Circulation.
100:e20–e28. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Libby P, Ridker PM and Maseri A:
Inflammation and atherosclerosis. Circulation. 105:1135–1143. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nieto FJ, Adam E, Sorlie P, Farzadegan H,
Melnick JL, Comstock GW and Szklo M: Cohort study of
cytomegalovirus infection as a risk factor for carotid
intimal-medial thickening, a measure of subclinical
atherosclerosis. Circulation. 94:922–927. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Smieja M, Gnarpe J, Lonn E, Gnarpe H,
Olsson G, Yi Q, Dzavik V, McQueen M and Yusuf S: Heart Outcomes
Prevention Evaluation (HOPE) Study Investigators: Multiple
infections and subsequent cardiovascular events in the heart
outcomes prevention evaluation (HOPE) study. Circulation.
107:251–257. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Celik S, Shankar V, Richter A, Hippe HJ,
Akhavanpoor M, Bea F, Erbel C, Urban S, Blank N, Wambsganss N and
Katus HA: Proinflammatory and prothrombotic effects on human
vascular endothelial cells of immune-cell-derived light. Eur J Med
Res. 14:147–156. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Halade GV, Jin YF and Lindsey ML: Matrix
metalloproteinase (MMP)-9: A proximal biomarker for cardiac
remodeling and a distal biomarker for inflammation. Pharmacol Ther.
139:32–40. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gao X, Xu X, Belmadani S, Park Y, Tang Z,
Feldman AM, Chilian WM and Zhang C: TNF-alpha contributes to
endothelial dysfunction by upregulating arginase in
ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol.
27:1269–1275. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Haidari M, Wyde PR, Litovsky S, Vela D,
Ali M, Casscells SW and Madjid M: Influenza virus directly infects,
inflames and resides in the arteries of atherosclerotic and normal
mice. Atherosclerosis. 208:90–96. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gurevich VS: Influenza, autoimmunity and
atherogenesis. Autoimmun Rev. 4:101–105. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Suo J, Zhao L, Wang J, Zhu Z, Zhang H and
Gao R: Influenza virus aggravates the ox-LDL-induced apoptosis of
human endothelial cells via promoting p53 signaling. J Med Virol.
87:1113–1123. 2015. View Article : Google Scholar : PubMed/NCBI
|
